Key result
PCOS is linked to altered glycerophospholipid metabolism via downregulation of LPCAT1 and PCYT1A.
Why the study?
The regulatory effects of DNA methylation on gene transcription and downstream lipid metabolism have not been explored in PCOS.
Case-Control
Methylation silencing of LPCAT1 and PCYT1A is associated with glycerophospholipid metabolism dysregulation in PCOS, providing a novel genetic and lipometabolic basis for its pathogenesis.
Answers are grounded in this paper and cite their sources.
Methylation changes in LPCAT1/PCYT1A may link to lipid alterations in PCOS; hypothesis-generating and requires prospective validation before clinical relevance.
Polycystic ovary syndrome (PCOS) is the most common endocrine diseases of fertile women and a major cause of infertility. The regulatory effects of DNA methylation on gene transcription and downstream lipid metabolism have not been explored in PCOS. In this study, MBD-seq and RNA-seq were performed on ovarian granulosa cells of PCOS patients and controls, and methylation specific PCR and quantitative polymerase chain reaction were used to validate the results. Then lipidomic profiling was conducted on serum of PCOS patients and controls using UPLC-MS. We identified 73 genes with differently methylated promoters and 830 differently expressed genes. The promoter regions of LPCAT1 and PCYT1A were hypermethylated, accompanied by downregulation of their messenger RNA expression, which may be involved in the regulation of PCOS through downstream glycerophospholipid metabolism and phosphatidylcholine synthesis. The lipid profiling results showed significant changes in 21 lipids, which demonstrated the disturbance in glycerophospholipid metabolism and glycerolipid metabolism pathways. Furthermore, the metabolites-genes interaction network was constructed to illustrate the association of aberrant methylome and transcriptome with lipidome alterations in glycerolipid and glycerophospholipid metabolism pathways. Our study suggested that the methylation silencing of LPCAT1 and PCYT1A may promote glycerophospholipids metabolism dysregulation, which provided a novel genetic and lipometabolic basis for the pathogenesis of PCOS.
No takes yet. Share an insight, caveat, or question.
Mao et al. (2021) conducted a case-control in Polycystic ovary syndrome. Polycystic ovary syndrome vs. Controls was evaluated on Differently methylated promoters, expressed genes, and lipidomic changes. Polycystic ovary syndrome was associated with hypermethylation and downregulation of LPCAT1 and PCYT1A, alongside significant changes in 21 lipids related to glycerophospholipid metabolism.
Synapse has enriched 10 related papers. Consider them for comparative context: